Laboratory for Organ Regeneration, Recovery, and Replacement (LOR3)

Welcome to the Laboratory for Organ Regeneration, Recovery, and Replacement (LOR3) at Vanderbilt University Medical Center.

The LOR3, directed by Matthew Bacchetta, MD, MBA, is focused on creating organ support systems that provide extended physiologic support for injured organs, bioengineering platforms for organ recovery and regeneration, and developing artificial cardiopulmonary assist systems. Our group is the first to develop a large pre-clinical cross-circulation platform for extracorporeal support of human lungs rejected for transplantation. We have also recently established a high-fidelity, titratable large pre-clinical model for pulmonary hypertension and right ventricular failure, a large pre-clinical platform that serves as a basis for developing the next-generation, durable mechanical support technology. Our work has been published in leading academic medical, scientific, and engineering journals, and also featured in major news outlets including The New York Times.  

The LOR3 is an interdisciplinary team of clinicians, scientists, engineers, nurses, surgeons and the S.R. Light Research and Training Laboratory personnel. If you are interested in joining our effort Contact Us.

Faculty and Staff of the LOR3 Lab

Projects

- Cross circulation platform for lungs and livers

- Immune characterization of xenogeneic XC

- Immune-reduced circuit design

- Safer, more durable mechanical cardiopulmonary support

- Clinical trials on anticoagulation regimen 

- Right heart support for pulmonary hypertension

- Improved vascular access for durable pulmonary assist system

- Use of pre-clinical model of right heart failure

- Application toward congestive hepatopathy

Publications and Presentations